© 1997 American Heart Association, Inc.
Articles |
Mechanisms of Action of Troglitazone in the Prevention of High Glucose–Induced Migration and Proliferation of Cultured Coronary Smooth Muscle Cells
From The First Department of Internal Medicine, Osaka City (Japan) University Medical School.
Correspondence to Kenichi Yasunari, MD, The First Department of Internal Medicine, Osaka City University Medical School, 1–5-7 Asahi-machi, Abeno-ku, Osaka 545, Japan.
Abstract
Abstract Recent findings suggest that high glucose levels may promote atherosclerosis in coronary vascular smooth muscle cells (VSMCs). To explore the intracellular mechanisms of action by which troglitazone affects this process, we examined the effect of troglitazone on the migration and growth characteristics of cultured rabbit coronary VSMCs. Treatment with chronic high glucose medium (22.2 mmol/L) for 5 days increased VSMC migration by 92%, [3H]thymidine incorporation by 135%, and cell number by 32% compared with VSMCs treated with normal glucose (5.5 mmol/L glucose+16.6 mmol/L mannose) medium. Troglitazone at 100 nmol/L and 1 µmol/L significantly suppressed high glucose–induced VSMC migration by 34% and 42%, respectively, the proliferative effect (as measured by cell number) by 17% and 27%, and [3H]thymidine incorporation by 45% and 60% (n=6, P<.05). The high glucose–induced impairment of insulin-mediated [3H]deoxyglucose uptake was blocked by a protein kinase C (PKC) inhibitor (calphostin C, 1 µmol/L) and was also improved by troglitazone without any change in insulin receptor number and affinity. The high glucose–induced insulin-mediated increase in cell number and in [3H]thymidine incorporation was suppressed by troglitazone. Troglitazone (1 µmol/L) also suppressed high glucose–induced phospholipase D activation, elevation of the cytosolic NADH/NAD+ ratio (as measured by the cytosolic ratio of lactate/pyruvate), and membrane-bound PKC activation. Flow cytometric DNA histogram analysis of cell cycle stage showed that high glucose–induced increase in the percentage of cells in the S phase was suppressed by 1 µmol/L troglitazone. These findings suggest that PKC may be a link between impairment of insulin-mediated glucose uptake and the increase in migration and proliferation induced by high glucose levels and that troglitazone may be clinically useful for the treatment of high glucose–induced coronary atherosclerosis.
Key Words: antioxidant • glucose • vascular smooth muscle • phospholipase D • protein kinase C
This article has been cited by other articles:
 |
|
 |
|
  K. V. Ramana, R. Tammali, A. B. M. Reddy, A. Bhatnagar, and S. K. Srivastava Aldose Reductase-Regulated Tumor Necrosis Factor-{alpha} Production Is Essential for High Glucose-Induced Vascular Smooth Muscle Cell Growth Endocrinology, September 1, 2007; 148(9): 4371 - 4384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-l. Li, M. A. Reddy, Q. Cai, L. Meng, H. Yuan, L. Lanting, and R. Natarajan Enhanced Proatherogenic Responses in Macrophages and Vascular Smooth Muscle Cells Derived From Diabetic db/db Mice Diabetes, September 1, 2006; 55(9): 2611 - 2619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Srivastava, K. V. Ramana, R. Tammali, S. K. Srivastava, and A. Bhatnagar Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes, April 1, 2006; 55(4): 901 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rask-Madsen and G. L. King Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 487 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Turturro, E. Friday, R. Fowler, D. Surie, and T. Welbourne Troglitazone Acts on Cellular pH and DNA Synthesis through a Peroxisome Proliferator-Activated Receptor {gamma}-Independent Mechanism in Breast Cancer-Derived Cell Lines Clin. Cancer Res., October 15, 2004; 10(20): 7022 - 7030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hamaguchi, T. Takamura, A. Shimizu, and Y. Nagai Tumor Necrosis Factor-{alpha} and Troglitazone Regulate Plasminogen Activator Inhibitor Type 1 Production through Extracellular Signal-Regulated Kinase- and Nuclear Factor-{kappa}B-Dependent Pathways in Cultured Human Umbilical Vein Endothelial Cells J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 987 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Hannan, R. J. Dilley, S. T. de Dios, and P. J. Little Troglitazone Stimulates Repair of the Endothelium and Inhibits Neointimal Formation in Denuded Rat Aorta Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 762 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jacob, J. D. Molkentin, A. Smolenski, S. M. Lohmann, and N. Begum Insulin inhibits PDGF-directed VSMC migration via NO/ cGMP increase of MKP-1 and its inactivation of MAPKs Am J Physiol Cell Physiol, September 1, 2002; 283(3): C704 - C713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yasunari, K. Maeda, M. Nakamura, and J. Yoshikawa Oxidative Stress in Leukocytes Is a Possible Link Between Blood Pressure, Blood Glucose, and C-Reacting Protein Hypertension, March 1, 2002; 39(3): 777 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Arima, K. Kohagura, K. Takeuchi, Y. Taniyama, A. Sugawara, Y. Ikeda, M. Abe, K. Omata, and S. Ito Biphasic Vasodilator Action of Troglitazone on the Renal Microcirculation J. Am. Soc. Nephrol., February 1, 2002; 13(2): 342 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yasunari, K. Maeda, M. Nakamura, and J. Yoshikawa Pressure Promotes Angiotensin II-Mediated Migration of Human Coronary Smooth Muscle Cells Through Increase in Oxidative Stress Hypertension, February 1, 2002; 39(2): 433 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wakino, U. Kintscher, Z. Liu, S. Kim, F. Yin, M. Ohba, T. Kuroki, A. H. Schonthal, W. A. Hsueh, and R. E. Law Peroxisome Proliferator-activated Receptor gamma Ligands Inhibit Mitogenic Induction of p21Cip1 by Modulating the Protein Kinase Cdelta Pathway in Vascular Smooth Muscle Cells J. Biol. Chem., December 7, 2001; 276(50): 47650 - 47657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Watson, A. Nesterova, C. F. Burant, D. J. Klemm, and J. E.-B. Reusch Diabetes-related Changes in cAMP Response Element-binding Protein Content Enhance Smooth Muscle Cell Proliferation and Migration J. Biol. Chem., November 30, 2001; 276(49): 46142 - 46150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Hupfeld and R. H. Weiss TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27 Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E207 - E216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yasunari, K. Maeda, M. Minami, and J. Yoshikawa HMG-CoA Reductase Inhibitors Prevent Migration of Human Coronary Smooth Muscle Cells Through Suppression of Increase in Oxidative Stress Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 937 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Li, P. M. Absher, P. Liang, J. C. Russell, B. E. Sobel, and N. K. Fukagawa High Glucose Concentrations Induce Oxidative Damage to Mitochondrial DNA in Explanted Vascular Smooth Muscle Cells Experimental Biology and Medicine, May 1, 2001; 226(5): 450 - 457. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Takagi, T. Akasaka, A. Yamamuro, Y. Honda, T. Hozumi, S. Morioka, and K. Yoshida Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: A serial intravascular ultrasound study J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1529 - 1535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yasunari, M. Kohno, H. Kano, M. Minami, and J. Yoshikawa Aldose Reductase Inhibitor Improves Insulin-Mediated Glucose Uptake and Prevents Migration of Human Coronary Artery Smooth Muscle Cells Induced by High Glucose Hypertension, May 1, 2000; 35(5): 1092 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Nordt, K. Peter, C. Bode, and B. E. Sobel Differential Regulation by Troglitazone of Plasminogen Activator Inhibitor Type 1 in Human Hepatic and Vascular Cells J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1563 - 1568. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Yasunari, M. Kohno, H. Kano, K. Yokokawa, M. Minami, and J. Yoshikawa Antioxidants Improve Impaired Insulin-Mediated Glucose Uptake and Prevent Migration and Proliferation of Cultured Rabbit Coronary Smooth Muscle Cells Induced by High Glucose Circulation, March 16, 1999; 99(10): 1370 - 1378. [Abstract] [Full Text] [PDF]
|
|